Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

2011548 citationsJournal Article

Authors

Genentech and Novartis Pharmaceuticals.

Published in: Annals of Internal Medicine

Volume 154, Issue 9, pp. 573-582

Field-Weighted Citation Impact: 16.06